The Effect of Innate Immunity on Autoimmune Diabetes and the Expression of Toll-Like Receptors on Pancreatic Islets

Journal of Immunology

Volumn 172, Issue 5, 2004, Pages 3173-3180

  Wen, Li ^a   Peng, Jian ^a   Li, Zhenjun ^b   Wong, F Susan ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INSULIN ANTIBODY; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TRANSGENE; VIRUS INFECTION;

EID: 1342302624     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.5.3173     Document Type: Article

References (45)

1. Kaprio, J., J. Tuomilehto, M. Koskenvuo, K. Romanov, A. Reunanen, J. Eriksson, J. Stengard, and Y. A. Kesaniemi. 1992. Concordance for type 1 (insulin-dependent) and type 2 (noninsulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 35:1060.
2. Kyvik, K. O., A. Green, and H. Beck-Nielsen. 1995. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. Br. Med. J. 311:913.
3. Redondo, M. J., L. Yu, M. Hawa, T. Mackenzie, D. A. Pyke, G. S. Eisenbarth, and R. D. Leslie. 2001. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44:354.
4. Gale, E. A. 2002. The rise of childhood type I diabetes in the 20th century. Diabetes 51:3353.
5. Atkinson, M. A., and G. S. Eisenbarth. 2001. Type I diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221.
6. Akerblom, H. K., O. Vaarala, H. Hyoty, J. Ilonen, and M. Knip. 2002. Environmental factors in the etiology of type 1 diabetes. Am. J. Med. Genet. 115:18.
7. Jun, H. S., and J. W. Yoon. 2003. A new look at viruses in type I diabetes. Diabetes Metab. Res. Rev. 19:8.
8. Hyoty, H., and K. W. Taylor. 2002. The role of viruses in human diabetes. Diabetologia 45:1353.
9. Horwitz, M. S., A. Ilic, C. Fine, E. Rodriguez, and N. Sarvetnick. 2002. Presented antigen from damaged pancreatic β cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J. Clin. Invest. 109:79.
10. + T cell populations. J. Immunol. 170:3592.
11. Liu, D., A. K. Cardozo, M. I. Darville, and D. L. Eizirik. 2002. Double-stranded RNA cooperates with interferon-γ and IL-1β to induce both chemokine expression and nuclear factor-κB-dependent apoptosis in pancreatic β-cells: potential mechanisms for viral-induced insulitis and β-cell death in type 1 diabetes mellitus. Endocrinology 143:1225.
12. Guidotti, L. G., and F. V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65.
13. Blair, L. A., M. R. Heitmeier, A. L. Scarim, L. B. Maggi, Jr., and J. A. Corbett. 2001. Double-stranded RNA-dependent protein kinase is not required for double-stranded RNA-induced nitric oxide synthase expression or nuclear factor-κB activation by islets. Diabetes 50:283.
14. Verdijk, R. M., T. Mutis, B. Esendam, J. Kamp, C. J. Melief, A. Brand, and E. Goulmy. 1999. Polyriboinosinic polyribocytidylic acid (poly(1:C)) induces stable maturation of functionally active human dendritic cells. J. Immunol. 163:57.
15. Mattei, F., G. Schiavoni, F. Belardelli, and D. F. Tough. 2001. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167:1179.
16. Cella, M., M. Salio, Y. Sakakibara, H. Langen, I. Julkunen, and A. Lanzavecchia. 1999. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 189:821.
17. Bogdan, C. 2000. The function of type I interferons in antimicrobial immunity. Curr. Opin. Immunol. 12:419.
18. Tough, D. F., P. Borrow, and J. Sprent. 1996. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947.
19. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189.
20. Sobel, D. O., D. Goyal, B. Ahvazi, J. W. Yoon, Y. H. Chung, A. Bagg, and D. M. Harlan. 1998. Low dose poly I:C prevents diabetes in the diabetes prone BB rat. J. Autoimmun. 11:343.
21. Ewel, C. H., D. O. Sobel, B. J. Zeligs, and J. A. Bellanti. 1992. Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes 41:1016.
22. Sobel, D. O., J. Newsome, C. H. Ewel, J. A. Bellanti, V. Abbassi, K. Creswell, and O. Blair. 1992. Poly I:C induces development of diabetes mellitus in BB rat. Diabetes 41:515.
23. Serreze, D. V., K. Hamaguchi, and E. H. Leiter. 1989. Immunostimulation circumvents diabetes in NOD/Lt mice. J. Autoimmun. 2:759.
24. Medzhitov, R., and C. Janeway, Jr. 2000. Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173:89.
25. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immun. 2:675.
26. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732.
27. Moriyama, H., L. Wen, N. Abiru, E. Liu, L. Yu, D. Miao, R. Gianani, F. S. Wong, and G. S. Eisenbarth. 2002. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc. Natl. Acad. Sci. USA 99:5539.
28. Guerder, S., D. E. Picarella, P. S. Linsley, and R. A. Flavell. 1994. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor α leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91:5138.
29. Judkowski, V., C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D. B. Wilson. 2001. Identification of MHC class 1I-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 166:908.
30. Wong, F. S., I. Visintin, L. Wen, R. A. Flavell, and C. A. Janeway, Jr. 1996. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183:67.
31. Scarim, A. L., M. Arnush, L. A. Blair, J. Concepcion, M. R. Heitmeier, D. Scheuner, R. J. Kaufman, J. Ryerse, R. M. Buller, and J. A. Corbett. 2001. Mechanisms of β-cell death in response to double-stranded (ds) RNA and interferon-γ: dsRNA-dependent protein kinase apoptosis and nitric oxide-dependent necrosis. Am. J. Pathol. 159:273.
32. Wong, F. S., J. Karttunen, C. Dumont, L. Wen, I. Visintin, I. M. Pilip, N. Shastri, E. G. Pamer, and C. A. Janeway, Jr. 1999. Identification of an MHC class I-restricted autoantigen in type I diabetes by screening an organ-specific cDNA library. Nat. Med. 5:1026.
33. Aderem, A., and R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406:782.
34. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune récognition. Annu. Rev. Immunol. 20:197.
35. Abim, N., L. Yu, D. Miao, A. K. Maniatis, E. Liu, H. Moriyama, and G. S. Eisenbarth. 2001. Transient insulin autoantibody expression independent of development of diabetes: comparison of NOD and NOR strains. J. Autoimmun. 17:1.
36. Daniel, D., R. G. Gill, N. Schloot, and D. Wegmann. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1056.
37. + T cell subsets in C57BL/6 mice. Cell. Immunol. 195:66.
38. +-autoreactive CTL expressing both type I and type 2 cytokines in C57BL/6 mice. J. Immunol. 164:86.
39. u haplotype rats. Diabetologia 43:890.
40. Stewart, T. A., B. Hultgren, X. Huang, S. Pitts-Meek, J. Hully, and N. J. MacLachlan. 1993. Induction of type I diabetes by interferon-α in transgenic mice. Science 260:1942.
41. Sobel, D. O., and B. Ahvazi. 1998. α-Interferon inhibits the development of diabetes in NOD mice. Diabetes 47:1867.
42. Foulis, A. K., M. A. Farquharson, and A. Meager. 1987. Immunoreactive α-interferon in insulin-secreting β cells in type 1 diabetes mellitus. Lancet 2:1423.
43. Huang, X., J. Yuang, A. Goddard, A. Foulis, R. F. James, A. Lernmark, R. Pujol-Borrell, A. Rabinovitch, N. Somoza, and T. A. Stewart. 1995. Interferon expression in the pancreases of patients with type I diabetes. Diabetes 44:658.
44. Diebold, S. S., M. Montoya, H. Unger, L. Alexopoulou, P. Roy, L. E. Haswell, A. Al-Shamkhani, R. Flavell, P. Borrow, and C. Reis e Sousa. 2003. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424:324.
45. Karges, W., K. Pechhold, S. Al Dahouk, I. Riegger, M. Rief, A. Wissmann, R. Schirmbeck, C. Barth, and B. O. Boehm. 2002. Induction of autoimmune diabetes through insulin (but not GAD65) DNA vaccination in nonobese diabetic and in RIP-B7.1 mice. Diabetes 51:3237.